PT1198224E - Formulacoes de solucoes de esteroides para administracao por inalacao - Google Patents

Formulacoes de solucoes de esteroides para administracao por inalacao

Info

Publication number
PT1198224E
PT1198224E PT00956216T PT00956216T PT1198224E PT 1198224 E PT1198224 E PT 1198224E PT 00956216 T PT00956216 T PT 00956216T PT 00956216 T PT00956216 T PT 00956216T PT 1198224 E PT1198224 E PT 1198224E
Authority
PT
Portugal
Prior art keywords
formulations
inhalation
management
steroid solutions
relates
Prior art date
Application number
PT00956216T
Other languages
English (en)
Inventor
Paolo Chiesi
Gaetano Brambilla
Raffaella Garzia
Chiara Malvolti
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of PT1198224E publication Critical patent/PT1198224E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
PT00956216T 1999-07-23 2000-07-20 Formulacoes de solucoes de esteroides para administracao por inalacao PT1198224E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999MI001625A IT1313553B1 (it) 1999-07-23 1999-07-23 Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.

Publications (1)

Publication Number Publication Date
PT1198224E true PT1198224E (pt) 2003-10-31

Family

ID=11383393

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00956216T PT1198224E (pt) 1999-07-23 2000-07-20 Formulacoes de solucoes de esteroides para administracao por inalacao

Country Status (14)

Country Link
US (1) US6967017B1 (pt)
EP (1) EP1198224B1 (pt)
AT (1) ATE241959T1 (pt)
AU (1) AU6825000A (pt)
CZ (1) CZ299071B6 (pt)
DE (1) DE60003183T2 (pt)
DK (1) DK1198224T3 (pt)
ES (1) ES2200913T3 (pt)
HU (1) HUP0201956A3 (pt)
IT (1) IT1313553B1 (pt)
NO (1) NO20020342D0 (pt)
PL (1) PL198817B1 (pt)
PT (1) PT1198224E (pt)
WO (1) WO2001007014A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20010614A1 (it) * 2001-10-16 2003-04-16 Italchimici S P A Preparazione farmaceutica di una soluzione idro/propilenica di budesonide e suo procedimento di preparazione.
US20040265238A1 (en) * 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
ITMI20032054A1 (it) 2003-10-22 2005-04-23 Monteres S R L Processo per la preparazione di sospensioni farmaceutiche da inalare.
AR041873A1 (es) * 2003-10-30 2005-06-01 Pablo Cassara Srl Lab Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
ITRM20040268A1 (it) * 2004-05-31 2004-08-31 Italchimici S P A Formulazione farmaceutica di una soluzione stabile di formoterolo per via inalatoria e suo precedimento di preparazione.
CN101119706B (zh) * 2005-02-25 2013-04-17 奇斯药制品公司 用于加压计量吸入器的包含螯合剂的药物气雾制剂
GB0604141D0 (en) * 2006-03-01 2006-04-12 Arrow Int Ltd Nebulizer formulation
CZ302596B6 (cs) * 2007-04-12 2011-07-27 Jihoceská univerzita v Ceských Budejovicích, Zemedelská fakulta Zpusob zpracování biomasy jetele lucního

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3361306A (en) 1966-03-31 1968-01-02 Merck & Co Inc Aerosol unit dispensing uniform amounts of a medically active ingredient
US3622053A (en) 1969-12-10 1971-11-23 Schering Corp Aerosol inhaler with flip-up nozzle
MX3864E (es) * 1975-05-27 1981-08-26 Syntex Corp Un proceso para prepara el compuesto cristalino 6-fluiro-11b 21-dihiroxi-16 17-isopropilidendioxipregna-1 4-dien-3 20-diona
US4185100A (en) 1976-05-13 1980-01-22 Johnson & Johnson Topical anti-inflammatory drug therapy
US4499108A (en) 1983-06-08 1985-02-12 Schering Corporation Stable pleasant-tasting albuterol sulfate pharmaceutical formulations
IT1196142B (it) 1984-06-11 1988-11-10 Sicor Spa Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti
US5192528A (en) 1985-05-22 1993-03-09 Liposome Technology, Inc. Corticosteroid inhalation treatment method
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5225183A (en) 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
IL97065A (en) 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
EP0563048A1 (en) 1990-12-19 1993-10-06 Smithkline Beecham Corporation Aerosol formulations
US6006745A (en) 1990-12-21 1999-12-28 Minnesota Mining And Manufacturing Company Device for delivering an aerosol
EP0504112A3 (en) 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
WO1992020391A1 (en) 1991-05-21 1992-11-26 Abbott Laboratories Aerosol inhalation device
PL169046B1 (pl) 1991-08-29 1996-05-31 Christoph Klein Przyrzad medyczny do inhalacji aerozolem PL PL PL PL PL
IL103238A (en) 1991-09-25 1995-07-31 Fisons Plc Pressed aerosol preparations
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
ES2159678T3 (es) 1991-12-18 2001-10-16 Minnesota Mining & Mfg Formulaciones de aerosol en suspension.
DE4230876A1 (de) 1992-03-17 1993-09-23 Asta Medica Ag Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten
DK0673240T3 (da) 1992-12-09 1999-10-11 Boehringer Ingelheim Pharma Stabiliserede medicinske aerosolopløsningsformuleringer
SE9203743D0 (sv) 1992-12-11 1992-12-11 Astra Ab Efficient use
AU4066693A (en) 1992-12-23 1994-07-19 Bernhard Hugemann Compacted drug body for use in the mechanical generation of inhalable active-substance particles
AU679511B2 (en) 1993-03-17 1997-07-03 Minnesota Mining And Manufacturing Company Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid
JPH08507792A (ja) 1993-03-17 1996-08-20 ミネソタ マイニング アンド マニュファクチャリング カンパニー ジオール−二酸から誘導される分散助剤を含むエーロゾル配合物
US6596260B1 (en) 1993-08-27 2003-07-22 Novartis Corporation Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol
DE69424181T2 (de) 1993-12-20 2000-10-19 Minnesota Mining & Mfg Flunisolide aerosolformulierungen
GB9425160D0 (en) 1994-12-10 1995-02-08 Glaxo Group Ltd Medicaments
HUT77775A (hu) 1994-12-22 1998-08-28 Astra Aktiebolag Aeroszolformák
GB9426252D0 (en) 1994-12-24 1995-02-22 Glaxo Group Ltd Pharmaceutical composition
DE4446891A1 (de) * 1994-12-27 1996-07-04 Falk Pharma Gmbh Stabile wäßrige Budesonid-Lösung
US5653961A (en) 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
CA2217950C (en) 1995-04-14 2001-12-25 Glaxo Wellcome Inc. Metered dose inhaler for albuterol
EP1769819A3 (en) 1995-04-14 2013-05-22 GlaxoSmithKline LLC Metered dose inhaler for fluticasone propionate
CA2218179A1 (en) 1995-04-14 1996-10-17 Glaxo Wellcome Inc. Metered dose inhaler for beclomethasone dipropionate
AP979A (en) 1995-04-14 2001-06-28 Glaxo Wellcome Inc Metered dose imhaler for salmeterol.
GB9612297D0 (en) 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
EP0914143A1 (en) 1996-07-08 1999-05-12 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation
WO1998003533A1 (en) 1996-07-24 1998-01-29 Oligos Etc. And Oligos Therapeutics, Inc. Antisense oligonucleotides as antibacterial agents
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
GB9620187D0 (en) 1996-09-27 1996-11-13 Minnesota Mining & Mfg Medicinal aerosol formulations
US6413496B1 (en) 1996-12-04 2002-07-02 Biogland Ireland (R&D) Limited Pharmaceutical compositions and devices for their administration
KR20000069275A (ko) 1996-12-04 2000-11-25 새들러 테리 아이언 약학 조성물과 그 투여를 위한 장치
WO1998034595A1 (de) 1997-02-05 1998-08-13 Jago Research Ag Medizinische aerosolformulierungen
US6126919A (en) 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
US5891419A (en) 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe flunisolide aerosol formulations for oral inhalation
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
GB2326334A (en) 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
BR7702049U (pt) 1997-09-05 1999-09-14 Chiesi Farma Spa Bico pulverizador para utilização em inalador oral para medicamentos aerossóis
NZ504021A (en) 1997-10-17 2003-04-29 Systemic Pulmonary Delivery Lt Method and apparatus for delivering aerosolized medication having air discharged through air tube directly into plume of aerosolized medication
US6045784A (en) 1998-05-07 2000-04-04 The Procter & Gamble Company Aerosol package compositions containing fluorinated hydrocarbon propellants
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
CA2335065C (en) 1998-06-18 2008-06-03 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6241969B1 (en) * 1998-06-26 2001-06-05 Elan Corporation Plc Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
ATE283033T1 (de) 1998-07-24 2004-12-15 Jago Res Ag Medizinische aerosolformulierungen
CN1150890C (zh) 1998-08-04 2004-05-26 杰格研究股份公司 药用气溶胶制剂
DE19847969A1 (de) 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Lagerfähig flüssige Formulierung mit Formoterol
CA2343123C (en) 1998-10-17 2008-03-25 Boehringer Ingelheim Pharma Kg Active substance concentrate with formoterol, suitable for storage
EP2266548B1 (de) 1998-11-13 2020-05-20 Jagotec AG Trockenpulver zur inhalation
IT1303788B1 (it) 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6290930B1 (en) 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
SK286981B6 (sk) 1999-03-05 2009-08-06 Chiesi Farmaceutici S.P.A. Prášok na použitie v inhalátore na suché prášky, nosič na tento prášok a spôsob výroby prášku
US6315985B1 (en) 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
ES2238334T3 (es) 1999-12-24 2005-09-01 Glaxo Group Limited Formulacion farmaceutica en aerosol de salmeterol y propionato de fluticasona.
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
WO2001089480A1 (en) 2000-05-22 2001-11-29 Chiesi Farmaceutici S.P.A. Stable pharmaceutical solution formulations for pressurised metered dose inhalers

Also Published As

Publication number Publication date
ITMI991625A0 (it) 1999-07-23
CZ2002257A3 (cs) 2002-05-15
EP1198224B1 (en) 2003-06-04
HUP0201956A2 (en) 2002-10-28
DE60003183T2 (de) 2004-04-29
IT1313553B1 (it) 2002-09-09
PL353470A1 (en) 2003-11-17
DK1198224T3 (da) 2003-09-29
ITMI991625A1 (it) 2001-01-23
NO20020342L (no) 2002-01-22
AU6825000A (en) 2001-02-13
EP1198224A1 (en) 2002-04-24
ATE241959T1 (de) 2003-06-15
WO2001007014A1 (en) 2001-02-01
HUP0201956A3 (en) 2003-10-28
NO20020342D0 (no) 2002-01-22
US6967017B1 (en) 2005-11-22
CZ299071B6 (cs) 2008-04-16
PL198817B1 (pl) 2008-07-31
ES2200913T3 (es) 2004-03-16
DE60003183D1 (de) 2003-07-10

Similar Documents

Publication Publication Date Title
BR9915095A (pt) Composição farmacêutica ministrável em aerosol
WO2005037246A3 (de) Wässrige aerosol-zubereitung
MA27702A1 (fr) Preparation de suspensions aqueuses steriles comprenant des ingredients actifs cristallins micronises, destinees a l'inhalation
TW200616650A (en) Semi-solid delivery vehicle and pharmaceutical compositions
HUP0202311A2 (hu) Aeroszollá alakított fertőzésgátló, gyulladásgátló és vértolulást gátló szerek az orrmelléküreg-gyulladás kezelésében
WO2007072503A3 (en) Combinations for managing inflammation and associated disorders
NO20062053L (no) Transdermalt, farmasoytisk preparat
BR0214806A (pt) Composições farmacêuticos de 5,7,14-triazatetraciclo-{10.3.1.02,11.0,4,9]-hexadeca-2(1 1),3,5,7,9-penteno
BRPI0009299B8 (pt) formas de administração farmacêuticas mecanicamente estáveis para administração por via oral, e, processo para produzir formas de administração farmacêuticas mecanicamente estáveis.
ATE299740T1 (de) Kombination aus einem no-donor und einem antioxidans zur behanndlung sexueller störungen
PT1198224E (pt) Formulacoes de solucoes de esteroides para administracao por inalacao
SE9904413D0 (sv) Comminuted form
DE60002885D1 (de) Wässrige formulierung zur nasalen verabreichung
WO2001047913A3 (de) Substituierte n-benzyl-indol-3-yl- glyoxylsäure-derivate antitumorwirkung
DK1280558T3 (da) Halvfast indgivelsesvehikel og farmaceutiske sammensætninger
ATE350024T1 (de) Flüssige zubereitung enthaltend tobramycin
ATE326947T1 (de) Thixotropes nasenspray
NO20013605D0 (no) Preparat for vorter
JPH11147825A (ja) 粘膜吸収性の向上方法及び粘膜外用剤
Bose et al. Lidocaine in bronchoscopy: Practical use and allergic reactions
EP1297838A4 (en) PRALMORELIN-CONTAINED NOSE DROP PREPARATIONS
Palomba et al. Oral use of interferon therapy in cervical human papillomavirus infection.
BR0205625A (pt) Formulações nasais
UA33773C2 (uk) Засіб для лікування патології нервово-м'язової системи та опірно-рухового апарату "ревмокаїн"